| Identification | Back Directory | [Name]
p38α inhibitor 1 | [CAS]
1034189-82-6 | [Synonyms]
p38α inhibitor 1
1H-Indazole-6-carboxamide, 5-(2,4-difluorophenoxy)-N-[2-(dimethylamino)ethyl]-1-(2-methylpropyl)- | [Molecular Formula]
C22H26F2N4O2 | [MOL File]
1034189-82-6.mol | [Molecular Weight]
416.46 |
| Chemical Properties | Back Directory | [Boiling point ]
527.1±50.0 °C(Predicted) | [density ]
1.23±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : ≥ 125 mg/mL (300.15 mM) | [form ]
Solid | [pka]
13.04±0.46(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
p38α inhibitor 1 is a p38α inhibitor extracted from patent WO 2008076265 A1. | [IC 50]
p38α | [References]
[1] Baker W, et al. Monophosphates as mutual prodrugs of anti-inflammatory signal transduction modulators (aistm's) and β-agonists for the treatment of pulmonary inflammation and bronchoconstriction. WO 2008076265 A1. |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310; |
| Website: |
https://www.weikeqi-biotech.com/ |
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|